Navigation Links
New study highlights Chagas disease as a growing health and socio-economic challenge
Date:2/8/2013

WASHINGON, D.C.February 7, 2013Today, The Lancet Infectious Diseases published a new report that examines the global economic burden of Chagas disease. In the first study of its kind, researchers measured the health and economic impact of Chagas disease and found that the total economic burden of Chagas disease matches or exceeds that of many more well-known diseases such as rotavirus, Lyme disease and cervical cancer.

Chagas disease infects an estimated 10 million people worldwide, with most cases occurring in Latin America. It is a parasitic infection transmitted through an insect commonly known as the "kissing bug." Its symptoms range from acute respiratory and intestinal infections to strokes, liver and heart disease. In some cases Chagas disease can be fatal.

The poorest countries in the region are especially impacted by this neglected tropical disease (NTD) because of the insect's propensity to live in impoverished communities that lack quality housing, access to essential medicines and vector control practices. However the new study found that while the burden is considerable in Latin America, it is also significant in parts of the world not traditionally considered risk areas for Chagas disease, such as in North America and Europe.

The study estimates that the global economic cost of Chagas disease exceeds USD $7 billion annually. This cost surpasses that of rotavirus ($2 billion) and cervical cancer ($4.7 billion). Even in the United States, the economic burden of Chagas disease is comparable to the burden of much more publicized infectious diseases such as Lyme disease. According to the study, currently infected individuals will result in more future health care costs occurring in the United States (approximately $6.7 billion) than any other country.

"Lost productivity is a big part of the cost," said the study's lead author, Dr. Bruce Lee. "By just focusing on health care costs, or simple measures such as death caused by the disease, we miss a lot of the burden. We must examine the crucial impact lost productivity can have on society, businesses, governments and other key stakeholders."

Quantifying the economic burden of Chagas disease can help guide public health policy decisions, according to the study's co-author, Dr. Peter Hotez.

"We now have more evidence that Chagas disease is more than just a burden on human health in some of the poorest countries. All around the world, Chagas disease has a huge economic impact," said Dr. Hotez. "This new data should help inform policy decisions that will prioritize Chagas disease on research, policy and development agendas. This should include support for developing new vaccines for Chagas disease."

The Sabin Vaccine Institute Product Development Partnership (Sabin PDP), in collaboration with Texas Children's Hospital, Baylor College of Medicine and other PDP partners, is currently engaged in early research and development for a bivalent therapeutic vaccine for the treatment of chronic Chagas disease. If successful, it would be the first therapeutic vaccine for the treatment of this disease.

"Further studies quantifying Chagas disease-related costs on a regional or country level will help policymakers and other decision makers establish necessary control measures," added Dr. Hotez.


'/>"/>

Contact: Johanna Harvey
johanna.harvey@sabin.org
202-621-1691
Sabin Vaccine Institute
Source:Eurekalert

Related medicine news :

1. On-the-Job Stress Wont Raise Your Risk for Cancer, Study Finds
2. Collaboration and innovation win CWRU School of Medicine grant to study gastric cancer
3. UIC researchers to study how young adults use e-cigarettes, snus
4. Docs, Families May Underestimate Patients Odds After Some Strokes: Study
5. Stroke During Childhood May Raise Risk for Epilepsy, Study Says
6. Social media may prove useful in prevention of HIV, STDs, study shows
7. Students in Educational First Steps Assisted Centers Show Persistent Benefits Far Beyond Early Childhood According to University of Texas at Dallas Study
8. Study Ties Gene to Dangerous Heart Valve Deposits
9. Electrical Brain Stimulation Plus Drug Fights Depression: Study
10. Mayo Clinic-led study identifies biomarkers for early risk assessment of acute kidney injury
11. Study to test whether hearing aids can help prevent falls
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... ... June 24, 2016 , ... Comfort Keepers® of San Diego, CA is ... Road To Recovery® program to drive cancer patients to and from their cancer treatments. ... the highest quality of life and ongoing independence. Getting to and from medical ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... People across ... in Genome magazine’s Code Talker Award, an essay contest in which patients and their ... award to be presented at the 2016 National Society of Genetic Counselors (NSGC) Annual ...
(Date:6/24/2016)... ... June 24, 2016 , ... The Haute Beauty Network, affiliated ... Weintraub as a prominent plastic surgeon and the network’s newest partner. , ... most handsome men, look naturally attractive. Plastic surgery should be invisible.” He stands ...
(Date:6/24/2016)... ... June 24, 2016 , ... Strategic ... Frederick area economy by obtaining investment capital for emerging technology companies. SCP ... that have already resulted in more than a million dollars of capital investment ...
(Date:6/24/2016)... ... ... Venture Construction Group (VCG) sponsors Luke’s Wings 5th Annual ... Country Club at 1201 Rockville Pike, Rockville, Maryland, 20852. The event raised funds ... been wounded in battle and their families. Venture Construction Group is a 2016 Silver ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... , June 23, 2016 Research ... "Pharmaceutical Excipients Market by Type (Organic Chemical (Sugar, Petrochemical, ... (Oral, Topical, Coating, Parenteral) - Global Forecast to 2021" ... The global pharmaceutical excipients market is ... a CAGR of 6.1% in the forecast period 2016 ...
(Date:6/23/2016)... Research and Markets has announced the addition of the ... to 2022" report to their offering. ... financial data derived from varied research sources to present unique ... on the market during the next five years, including a ... markets, regional and country level analysis. The report provides a ...
(Date:6/23/2016)... 2016 Bracket , a leading clinical trial ... clinical outcomes platform, Bracket eCOA (SM) 6.0, at the ... – 30, 2016 in Philadelphia , Pennsylvania.  ... Assessment product of its kind to fully integrate with RTSM, ... eCOA 6.0 is a flexible platform for electronic clinical outcomes ...
Breaking Medicine Technology: